November 16, 2017

DrugDev to Showcase its DrugDev Spark™ Unified Clinical Suite Used on Over 2,000 Trials in Over 60 Countries at Partnerships in Clinical Trials Europe

Pharmaceutical and biotechnology companies of all sizes standardize on DrugDev Spark as one single platform to transform key aspects of clinical operations including site selection and activation, payments, eConsent, site engagement, training and document exchange

London UK and Philadelphia PA – As demand for DrugDev Spark™ continues to skyrocket worldwide, DrugDev, an IQVA company, will bring the groundbreaking unified clinical suite of proven solutions used on 2,000+ clinical trials in over 60 countries to Partnerships in Clinical Trials Europe, 28-29 November, RAI, Amsterdam.

Attendees will see firsthand why global pharmaceutical and biotechnology companies of all sizes standardize on DrugDev Spark to transform clinical operations. DrugDev Spark is unique in its ability to integrate proven solutions for site selection and feasibility, site activation, payments, eConsent, site engagement, LMS and document exchange into a single platform with one login and a consistent, familiar interface for sites.

DrugDev executives and subject matter experts on hand will include:

  • George Masoura, Vice President, Business Development, Europe
  • Stewart Mackie, Vice President, Global Site Payments
  • Karen Maduschke, Director of Training & Support, Patient Solutions/eConsent
  • Kirsty Kwiatkowski, VP, Business Operations, SiteStart

Click here to schedule a hands-on demonstration of DrugDev Spark technology to transform your clinical trials at Booth #31, where you also can enter the raffle for an Apple watch. Attendees also will be the first to get a sneak peek at exciting new features coming in 2018.

In addition, DrugDev welcomes attendees to enjoy a Winter Wonderland Reception and Photo Booth in the RAI Boathouse on 28 November, 6-8 pm to capture the moment and the spirit of the holidays with colleagues.

DrugDev’s mission is to enable pharma and biotech to do more trials and bring new medicines to patients who need them through industry-wide collaboration, standardization, and a beautiful technology experience. Learn more about the company and the DrugDev Spark unified clinical operations suite at

About DrugDev

DrugDev, an IQVIA company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience.  DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on over 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at